Cover Image
Market Research Report

Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016

Published by Global Markets Direct Product code 341863
Published Content info 42 Pages
Delivery time: 1-2 business days
Price
Back to Top
Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016
Published: September 30, 2016 Content info: 42 Pages
Description

Summary

Global Markets Direct's, 'Foamix Pharmaceuticals Ltd. - Product Pipeline Review - 2016', provides an overview of the Foamix Pharmaceuticals Ltd.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Foamix Pharmaceuticals Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Foamix Pharmaceuticals Ltd.
  • The report provides overview of Foamix Pharmaceuticals Ltd. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Foamix Pharmaceuticals Ltd.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Foamix Pharmaceuticals Ltd.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Foamix Pharmaceuticals Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Foamix Pharmaceuticals Ltd.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Foamix Pharmaceuticals Ltd.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Product Code: GMDHC08140CDB

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Foamix Pharmaceuticals Ltd. Snapshot
    • Foamix Pharmaceuticals Ltd. Overview
    • Key Facts
  • Foamix Pharmaceuticals Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Foamix Pharmaceuticals Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Foamix Pharmaceuticals Ltd. - Pipeline Products Glance
    • Foamix Pharmaceuticals Ltd. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Foamix Pharmaceuticals Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Foamix Pharmaceuticals Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Foamix Pharmaceuticals Ltd. - Drug Profiles
    • (urea + lactic acid) - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • acyclovir - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • benzoyl peroxide - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • betamethasone valerate - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • ciclopirox olamine - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • doxycycline - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • estradiol hemihydrate - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • FMX-101 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • FMX-102 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • FMX-103 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • imiquimod - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • mometasone furoate - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • urea - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Foamix Pharmaceuticals Ltd. - Pipeline Analysis
    • Foamix Pharmaceuticals Ltd. - Pipeline Products by Target
    • Foamix Pharmaceuticals Ltd. - Pipeline Products by Route of Administration
    • Foamix Pharmaceuticals Ltd. - Pipeline Products by Molecule Type
    • Foamix Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action
  • Foamix Pharmaceuticals Ltd. - Dormant Projects
  • Foamix Pharmaceuticals Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Foamix Pharmaceuticals Ltd., Key Facts
  • Foamix Pharmaceuticals Ltd. - Pipeline by Indication, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2016
  • Foamix Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2016
  • Foamix Pharmaceuticals Ltd. - Combination Treatment Modalities in Pipeline, 2016
  • Foamix Pharmaceuticals Ltd. - Partnered Products in Pipeline, 2016
  • Foamix Pharmaceuticals Ltd. - Partnered Products/ Combination Treatment Modalities, 2016
  • Foamix Pharmaceuticals Ltd. - Phase III, 2016
  • Foamix Pharmaceuticals Ltd. - Phase II, 2016
  • Foamix Pharmaceuticals Ltd. - Phase I, 2016
  • Foamix Pharmaceuticals Ltd. - Preclinical, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline by Target, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2016
  • Foamix Pharmaceuticals Ltd. - Dormant Developmental Projects,2016
  • Foamix Pharmaceuticals Ltd., Subsidiaries

List of Figures

  • Foamix Pharmaceuticals Ltd. - Pipeline by Top 10 Indication, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline by Stage of Development, 2016
  • Foamix Pharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline by Target, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline by Route of Administration, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline by Molecule Type, 2016
  • Foamix Pharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2016
Back to Top